| Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients | |
| Feng, Zheng; Wen, Hao; Bi, Rui; Duan, Yachen; Yang, Wentao; Wu, Xiaohua | |
| 刊名 | BMC CANCER
 |
| 2016 | |
| 卷号 | 16 |
| 关键词 | Ovarian cancer Platelet Fibrinogen Tumor burden Prognosis |
| ISSN号 | 1471-2407 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3625169 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Feng, Zheng,Wen, Hao,Bi, Rui,et al. Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients[J]. BMC CANCER,2016,16. |
| APA | Feng, Zheng,Wen, Hao,Bi, Rui,Duan, Yachen,Yang, Wentao,&Wu, Xiaohua.(2016).Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients.BMC CANCER,16. |
| MLA | Feng, Zheng,et al."Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients".BMC CANCER 16(2016). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论